Introduction
Type I interferons (IFNs), the main effector cytokines against viral infections are induced mainly via the activation of pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs), RIG-I-like receptors (RLRs) and the newly identified STING-dependent pathways that recognize microbial and self-DNA as well as cyclic dinucleotides in the cytoplasm (Kumar et al., 2011; Paludan and Bowie, 2013) . While produced in large amounts during infections, it has long been acknowledged that type I IFNs are also produced spontaneously albeit at very low levels in the absence of infection (Lienenklaus et al., 2009 ). Such constitutively produced type I IFNs play a vital role in priming and maintaining the innate immune system in a "ready to go" state for prompt response upon microbial encounter (Hata et al., 2001; Taniguchi and Takaoka, 2001) . Consequently, subtle changes in constitutive production of type I IFNs can have profound effects on the magnitude and quality of immune response elicited by microbes or other environmental danger signals (Gough et al., 2012; Hata et al., 2001; Taniguchi and Takaoka, 2001) . Accordingly, if chronic, elevated constitutive type I IFNs may contribute to undesirable inflammatory responses and possibly autoimmunity (Arakura et al., 2007; Gough et al., 2012; Taniguchi and Takaoka, 2001 ). The molecular events underlying constitutive type I IFN induction and how defects in such events impact the onset and progression of disease remain unclear.
DNA damage is a constant threat to all eukaryotic life. DNA damage can be a result of exogenous genotoxic agents such as irradiation, UV light or chemical mutagens or due to endogenous genotoxic events such as DNA replication, recombination errors, metabolic genotoxins or oxidative stress. Of the various forms of damages inflicted by these mutagens, double-strand breaks (DSB) of DNA are the most toxic form. Ataxia-telangiectasia mutated (ATM) kinase plays a central role in double-strand DNA repair. In humans, loss of function mutations in ATM results in Ataxia Telangiectasia (AT), a complex cancer prone neurodegenerative disease that displays a variety of inflammatory and autoimmune syndromes whose etiology remains unclear (Ammann and Hong, 1971; Deng et al., 2005; Kutukculer and Aksu, 2000; McGrath-Morrow et al., 2010; Shao et al., 2009; Westbrook and Schiestl, 2010) . Furthermore, AT is associated with a peculiar susceptibility to respiratory bacterial infections (Boder and Sedgwick, 1958; Nowak-Wegrzyn et al., 2004; Schroeder and Zielen, 2013) and chronic herpesvirus infections (Kulinski et al., 2012; Masucci et al., 1984) .
Whereas such infections are presumed to be a result of defects in the adaptive immune system, curiously, severe systemic viral infections are disproportionately uncommon in such patients (Boder and Sedgwick, 1958; Nowak-Wegrzyn et al., 2004; Schroeder and Zielen, 2013) . Whether ATM dysfunctions affect the innate immune system and whether that may contribute to AT associated features has not been addressed.
Here we show that accumulation of spontaneous DNA lesions in the absence of ATM or in response to exogenous genotoxic stress induces type I IFNs and that this primes the innate immune system for an amplified type I IFN response upon viral and bacterial encounter. We show that DNA damage induced type I IFN production is due to activation of STING pathway by self-DNA released into the cytoplasm.
Results

Loss of ATM function results in a spontaneous type I interferon response
While analyzing the role of ATM in innate immunity, we observed that sera from infectionfree AT patients could protect HEK293 cells against the RNA virus, Vesicular stomatitis virus (VSV-GFP) ( Figure 1A, B) . The sera could activate expression of the interferon stimulated gene Mx1 and nuclear factor- B (NF-κB) responses in HEK293 luciferase reporter cells ( Figure 1C, D) , indicating that ATM deficiency in human results in spontaneous systemic inflammation. We next analyzed fibroblasts from AT patients for the expression of type I IFN genes. Compared to those from apparently healthy subjects, AT patient fibroblasts had constitutively elevated transcripts for type I IFN genes IFNB1 and MX1 as well as for the type III IFN gene IFN-λ1 ((IFNL1) ( Figure 1E ). Upon infection with VSV-GFP, AT fibroblasts were found to elicit a higher IFNB1 response ( Figure 1F ) that correlated with diminished viral replication and progeny virus production ( Figure 1G, H) . Notably, silencing of IFNα and IFNβ receptor (IFNAR1) by shRNA rendered AT patient fibroblasts more permissive to VSV infection ( Figure 1I , J) emphasizing the importance of type I IFNs in observed resistance of AT patient cells to VSV infection. To extend these findings, we also tested the responsiveness of AT patient cells to the DNA virus, type I herpes simplex virus (HSV1).
Similarly, AT patient cells mounted a more robust IFNB1 response and resistance to HSV1 replication ( Figure 1K, L) . Together these results demonstrate that ATM dysfunction results in spontaneous type I IFN production which primes cells for an amplified anti-viral innate immune response.
To further study this phenomenon, we resorted to Atm -/-mice. Splenocytes ( Figure S1A ) and bone marrow derived macrophages (BMDMs) ( Figure S1B) Figure S2C) . Similarly, when infected with luciferase reporter HSV1 (HSV1-luc) strain (Summers and Leib, 2002) , Atm silenced cells exhibited decreased HSV1 replication that coincided with enhanced Ifnb1 response ( Figure   S2D , E). Together, these results indicate that loss of ATM results in a primed innate immune system which is more responsive and hence protective against viral infection. 2012; Ishikawa et al., 2009; Woodward et al., 2010) . Atm -/-BMDMs were found to elicit a higher IFN-β -luciferase response in response to L. monocytogenes infection ( Figure S2F ).
To elucidate which PRR pathways are primed by loss of ATM, BMDMs were stimulated with Figure   3C ), demonstrating that amplified proximal PRR signaling and consequently type I IFN response in Atm -/-cells were due to the priming effect of spontaneously produced type I IFNs.
We also extended these analyses to VSV-AV2 infection. Atm -/-BMDMs exhibited elevated activation of proximal PRR signaling molecules including TBK1, p38 MAPK, and IRF3
( Figure 3D) . Concomitantly, such cells displayed more a robust type I IFN response and hence an inhibited replication of VSV-AV2 ( Figure 3E, F 
Loss of ATM primes the type I IFN system via STING pathway
Next we sought to investigate whether the primed type I IFN state caused by loss of ATM was also dependent on the STING pathway. In this regard we ask whether ablation of ATM in the CytExt) or γ-irradiated Wt BMDMs (Wt/5Gy CytExt) were found to be enriched in nucleic acids. Upon further analysis, such CytExt DNA was found to be highly sensitive to ssDNA degrading enzyme S1 nuclease, but showed moderate sensitivity to DNase I which degrades dsDNA ( Figure 7A-C) . Thus, whereas a major fraction of DNA released into the cytoplasm upon DNA damage might be ssDNA, it appears that dsDNA also contributes. To study ssDNA in a more specific manner, we stained cytoplasm of Wt and Atm -/-BMDMs with anti-ssDNA antibody and analyzed by flow cytometry. Atm -/-BMDMs showed positive staining for ssDNA that was sensitive to S1 nuclease treatment ( Figure 7D ).
Immunofluoresence microscopic analysis also confirmed accumulation of ssDNA in Finally and more broadly, the present findings establish a role of DNA damage in reviving up the innate immune system for enhanced anti-microbial innate immune responses.
Consequently, tampering with DNA damage repair machinery, such as a kinase ATM, results in spontaneous production of type I IFNs which while priming the innate immune system for a robust anti-viral defense might on the other hand contribute to unwarranted inflammation, much to the host´s detriment. Thus the type I IFN system under normal homeostatic conditions appears to be well balanced between priming and inflammation.
Experimental Procedures Ethics statement
Experiments involving human subjects were done according to the recommendations of the local Research Ethics Committee of Umeå University (Regionala etikprövningsnämnden i Umeå) Sweden, as approved in permit Dnr 2012-501-31M. Fully informed consent was obtained from healthy and AT patients, in compliance with the Declaration of Helsinki. All mice were maintained under specific pathogen free conditions and experiments were approved and carried out according to the guidelines set out by the Regional Animal Ethic
Committee Approval #A107-11 or A126-12.
In vivo animal experiments
In vivo infection experiments were performed in Umeå Center for Comparative Biology 
FACS analysis of ssDNA
BMDMs were fixed in 80 % methanol in PBS, ±150 mM NaCl, without further treatment prior to adding antibody. Cells were pretreated with 200 U/ml S1 nuclease (Invitrogen) at 37 °C for 1 hr as indicated. FACS analysis of ssDNA-labeled cells were performed and analyzed by a Becton Dickinson FACSCalibur flow cytometer.
Purification of Cytoplasmic DNA
Cytoplasmic extract (CytExt) was isolated as previously described with minor modifications (Yang et al., 2007) . Briefly, Wt, Wt + 5Gy γ-irradiated and Atm -/-BMDMs were lysed in plus protease inhibitors for 5 min on ice with 0.1 % (v/v) Triton X-100, and nuclei were removed by low-speed centrifugation (1500 x g, 10 min). Cytoplasmic protein extracts were treated with 1 mg/ml Proteinase K at 55 °C for 1 h. After phenol/chloroform extraction, the aqueous supernatant was incubated with 500 μg/ml DNase-free RNase A (QIAGEN) for 30 min at 37 °C, again followed by phenol/chloroform extraction. The DNA-containing aqueous phase was precipitated, resuspended in TE buffer, DNA concentrations were adjusted to the protein concentration of cytoplasmic fractions and analyzed by a 2 % (w/v) agarose gel in 1 x TBE buffer with 1 x GelRed stain (Biotium, Madison, WI) incorporated in gel.
Statistical analysis
All data are shown as mean ± S.E.M. Statistical analysis was performed using a two-tailed Rice, G., Newman, W.G., Dean, J., Patrick, T., Parmar, R., Flintoff, K., Robins, P., Harvey, S., Hollis, T., O'Hara, A., et al. (2007) . Taniguchi, T., and Takaoka, A. (2001) . A weak signal for strong responses: interferonalpha/beta revisited. Nature reviews. Molecular cell biology 2, 378-386.
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Supplemental Experimental Procedures Mice
Luciferase assay
Cells were lysed in 30 μl lysis buffer containing 0,2 % (v/v) Triton-X-100, 10 % (v/v) glycerol in phosphate-buffered saline (PBS). 25 μl of each lysate was mixed with 50 μl of Luciferase Assay Reagent (Promega) and measured for luciferase activity using TECAN Infinite M1000 PRO multi-mode microplate reader. Relative luminescence units were normalized to protein concentration and expressed as fold-change in relation to unstimulated wild-type values.
Reagents and antibodies
Lipopolysaccharide (LPS), gentamicin, etoposide, mouse anti-α-Tubulin antibody, shRNAs against mouse Atm, Trex1, cGAS, Ifi204, human IFNAR1 were from Sigma-Aldrich.
Pam 3 CSK 4 , c-di-GMP, Poly (I:C), Poly (dA:dT) and Lyovec (transfection reagent) were from Invivogen. S1 nuclease was from Invitrogen. Dnase I was from Thermo Scientific.
Rabbit anti-TBK1 and rabbit anti-p-TBK1 antibodies were obtained from Abcam. Mouse anti-ssDNA antibody was from Merck-Millipore. Goat anti-γ-H2A.X, rabbit anti-p-γ-H2A.X
Quantitative Real-time PCR analysis
RNA was isolated from cells using RNeasy kit from Qiagen. 1 μg of total RNA was reverse transcribed using oligo ( The following oligonucleotides were used as controls for ssDNA: ssDNA 110 (5´-ctgcagcctga atatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggaacagctgaatatgggccaaa caggatatctgt-3´), Self annealing ssDNA 110 (5´-ctgcagcctgaatatgggccaaacaggatatctgtggtaagca gttcctgccccgTcggggcaggaactgcttaccacagatatcctatttggcccatattcaggctgcag-3´)
